i
Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method
-
Sep 01 2016
-
-
Source: Eur Respir J. 2016; 48(4):1160-1170.
Details:
-
Alternative Title:Eur Respir J
-
Personal Author:
-
Description:Debate persists about monitoring method (culture or smear) and interval (monthly or less frequently) during treatment for multidrug-resistant tuberculosis (MDR-TB). We analysed existing data and estimated the effect of monitoring strategies on timing of failure detection.We identified studies reporting microbiological response to MDR-TB treatment and solicited individual patient data from authors. Frailty survival models were used to estimate pooled relative risk of failure detection in the last 12 months of treatment; hazard of failure using monthly culture was the reference.Data were obtained for 5410 patients across 12 observational studies. During the last 12 months of treatment, failure detection occurred in a median of 3 months by monthly culture; failure detection was delayed by 2, 7, and 9 months relying on bimonthly culture, monthly smear and bimonthly smear, respectively. Risk (95% CI) of failure detection delay resulting from monthly smear relative to culture is 0.38 (0.34-0.42) for all patients and 0.33 (0.25-0.42) for HIV-co-infected patients.Failure detection is delayed by reducing the sensitivity and frequency of the monitoring method. Monthly monitoring of sputum cultures from patients receiving MDR-TB treatment is recommended. Expanded laboratory capacity is needed for high-quality culture, and for smear microscopy and rapid molecular tests.
-
Subjects:
-
Source:
-
Pubmed ID:27587552
-
Pubmed Central ID:PMC5045442
-
Document Type:
-
Funding:
-
Volume:48
-
Issue:4
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: